These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Transfusion-associated GVHD: 10 years' experience at the American University of Beirut-Medical Center. Aoun E; Shamseddine A; Chehal A; Obeid M; Taher A Transfusion; 2003 Dec; 43(12):1672-6. PubMed ID: 14641862 [TBL] [Abstract][Full Text] [Related]
11. Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial. Deeg HJ; Lin D; Leisenring W; Boeckh M; Anasetti C; Appelbaum FR; Chauncey TR; Doney K; Flowers M; Martin P; Nash R; Schoch G; Sullivan KM; Witherspoon RP; Storb R Blood; 1997 May; 89(10):3880-7. PubMed ID: 9160697 [TBL] [Abstract][Full Text] [Related]
12. Transfusion associated graft-versus-host disease after cardiac surgery: response to antithymocyte-globulin and corticosteroid therapy. Prince M; Szer J; van der Weyden MB; Pedersen JS; Holdsworth RF; Whyte G Aust N Z J Med; 1991 Feb; 21(1):43-6. PubMed ID: 2036076 [TBL] [Abstract][Full Text] [Related]
13. A randomized study of cyclosporine and methotrexate with or without methylprednisolone for the prevention of graft-versus-host disease: Improved long-term survival with triple prophylaxis. Ruutu T; Nihtinen A; Niittyvuopio R; Juvonen E; Volin L Cancer; 2018 Feb; 124(4):727-733. PubMed ID: 29112242 [TBL] [Abstract][Full Text] [Related]
14. Transfusion induced Graft versus host disease - Case report in a 2 year child. Naveen KN; Kabbin GM; Kulkarni V; Pai VV; Rao R Transfus Apher Sci; 2012 Aug; 47(1):17-9. PubMed ID: 22475546 [TBL] [Abstract][Full Text] [Related]
15. [Genetic diagnosis for post-transfusion graft-versus-host disease using PCR amplification of variable number of tandem repeats]. Uchida S; Yahagi H Nihon Rinsho; 1997 Sep; 55(9):2267-71. PubMed ID: 9301288 [TBL] [Abstract][Full Text] [Related]
16. Transfusion-associated graft-versus-host disease in an immunocompetent patient following accidental injury. Kobayashi H; Kitano K; Kishi E; Hara K; Ishida F; Saito H; Ota M; Furuta S Am J Hematol; 1993 May; 43(1):51-3. PubMed ID: 8317463 [TBL] [Abstract][Full Text] [Related]
17. Transfusion-associated graft versus host disease in the immunocompetent patient: an ongoing problem. Jawa RS; Young DH; Stothert JC; Kulaylat MN; Landmark JD J Intensive Care Med; 2015 Mar; 30(3):123-30. PubMed ID: 23792801 [TBL] [Abstract][Full Text] [Related]
18. Transfusion-associated graft-versus-host disease in an immunocompetent patient. Capon SM; DePond WD; Tyan DB; Pepkowitz SH; Toyoda H; Cinman AC; Azer PC; Goldfinger D Ann Intern Med; 1991 Jun; 114(12):1025-6. PubMed ID: 2029098 [No Abstract] [Full Text] [Related]
19. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation. Michallet M; Perrin MC; Belhabri A; Molina L; Nicolini F; Tigaud JD; Sotto JJ; Guyotat D; Fière D; Archimbaud E Bone Marrow Transplant; 1999 Jan; 23(2):145-50. PubMed ID: 10197799 [TBL] [Abstract][Full Text] [Related]
20. Results with histological diagnosis in kidney transplant rejections treated with 15-deoxyspergualin. Kyo M; Ichikawa Y; Hanafusa T; Fukunishi T; Nagano S; Takahara S; Kokado Y; Okuyama A; Ihara H; Ito K; Sagawa S; Sonoda T; Akiyama T; Kurita T; Suzuki S; Amemiya H Transplant Proc; 1996 Apr; 28(2):910-1. PubMed ID: 8623457 [No Abstract] [Full Text] [Related] [Next] [New Search]